These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30655983)

  • 1. Basal cell carcinoma of the prostate: A case report and review of the literature.
    Shibuya T; Takahashi G; Kan T
    Mol Clin Oncol; 2019 Jan; 10(1):101-104. PubMed ID: 30655983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basal cell carcinoma of prostate: a report of three cases].
    Liu Z; Ma LL; Zhang SD; Lu M; Tian Y; He Q; Jin J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):720-724. PubMed ID: 29263520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nondissection of pelvic lymph nodes does not influence the results of perineal radical prostatectomy in selected patients.
    Salomon L; Hoznek A; Lefrère-Belda MA; Bellot J; Chopin DK; Abbou CC
    Eur Urol; 2000 Mar; 37(3):297-300. PubMed ID: 10720855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basaloid carcinoma of the prostate: an extremely rare tumor.
    Rodriguez-Carlin A; Arellano L; López-Fontana G; Bolufer E; Castillo OA
    Arch Esp Urol; 2013 May; 66(4):380-4. PubMed ID: 23676544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basal cell carcinoma of prostate: a report of three cases].
    Liu Z; Ma LL; Zhang SD; Lu M; Tian Y; He Q; Jin J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):720-4. PubMed ID: 27538159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial prostate cancer: a different disease?
    Kupelian PA; Klein EA; Witte JS; Kupelian VA; Suh JH
    J Urol; 1997 Dec; 158(6):2197-201. PubMed ID: 9366343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
    Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.
    McKenney JK; Amin MB; Srigley JR; Jimenez RE; Ro JY; Grignon DJ; Young RH
    Am J Surg Pathol; 2004 Oct; 28(10):1289-98. PubMed ID: 15371944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic Salvage Lymph Node Dissection After Radical Prostatectomy.
    Torricelli FC; Cividanes A; Guglielmetti GB; Coelho RF
    Int Braz J Urol; 2015; 41(4):819; discussion 820. PubMed ID: 26401879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoid cystic/basal-cell carcinoma of the prostate following high-grade urothelial bladder cancer: a case report.
    Glavinov MS; Krsteska B; Stojmenova V; Petrovska T; Jovanovic R
    Oxf Med Case Reports; 2024 May; 2024(5):omae050. PubMed ID: 38784775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adenoid cystic/basal cell carcinoma of the prostate:case report].
    Tonini G; Rosini R; Teppa A; Aulenti V; Kalantary F; Tosana M; Bianchi D; Zorzi F
    Urologia; 2008; 75(4):245-8. PubMed ID: 21086341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P; Katcher J; Levin H; Zippe C; Klein E
    Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence after radical prostatectomy for organ-confined prostate cancer.
    Scheepe JR; Vis AN; Mickisch GH
    Onkologie; 2003 Aug; 26(4):330-3. PubMed ID: 12972697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcomes of laparoscopic radical prostatectomy for high risk prostate cancer].
    Shao P; Yin C; Li J; Li P; Ju X; Lyu Q; Meng X; Hua L
    Zhonghua Wai Ke Za Zhi; 2015 Nov; 53(11):847-51. PubMed ID: 26813840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
    Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
    Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.